ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 165 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2017. The put-call ratio across all filers is 1.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,602 | -69.6% | 73 | -50.0% | 0.00% | – |
Q2 2023 | $8,546 | +65.0% | 146 | +100.0% | 0.00% | – |
Q1 2023 | $5,179 | +32268.8% | 73 | -68.0% | 0.00% | – |
Q4 2022 | $16 | -99.8% | 228 | +60.6% | 0.00% | – |
Q3 2022 | $10,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q2 2022 | $10,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q1 2022 | $10,000 | – | 142 | +3450.0% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 4 | -71.4% | 0.00% | – |
Q1 2021 | $2,000 | -50.0% | 14 | -56.2% | 0.00% | – |
Q4 2020 | $4,000 | +300.0% | 32 | +220.0% | 0.00% | – |
Q3 2020 | $1,000 | – | 10 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | – | 14 | +250.0% | 0.00% | – |
Q3 2017 | $0 | – | 4 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 4 | 0.0% | 0.00% | – |
Q1 2017 | $0 | – | 4 | 0.0% | 0.00% | – |
Q4 2016 | $0 | – | 4 | 0.0% | 0.00% | – |
Q3 2016 | $0 | – | 4 | 0.0% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 4 | -63.6% | 0.00% | – |
Q4 2015 | $1,000 | – | 11 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 38,100 | $2,928,000 | 1.67% |
Opaleye Management Inc. | 80,000 | $6,149,000 | 1.59% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 410,000 | $31,517,000 | 1.06% |
Opus Point Partners Management, LLC | 6,311 | $485,000 | 1.05% |
SECTOR GAMMA AS | 68,015 | $5,228,000 | 0.87% |
Capital Impact Advisors, LLC | 27,074 | $2,061,000 | 0.76% |
FORTALEZA ASSET MANAGEMENT INC/ | 1,130 | $87,000 | 0.71% |
CAPITAL INTERNATIONAL LTD /CA/ | 46,957 | $3,610,000 | 0.63% |
Virtus ETF Advisers LLC | 8,794 | $676,000 | 0.60% |
Rock Springs Capital Management LP | 200,000 | $15,374,000 | 0.59% |